Alan W. Weber’s PDL BioPharma, Inc. PDLI Stock Holding History

Alan W. Weber’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200,000	Closed	-$630K	–	87
2020 Q3	$630K	Hold	200,000	–	–	0.29%	39
2020 Q2	$582K	Hold	200,000	–	–	0.3%	43
2020 Q1	$564K	Hold	200,000	–	–	0.4%	39
2019 Q4	$650K	Hold	200,000	–	–	0.26%	44
2019 Q3	$432K	Hold	200,000	–	–	0.19%	48
2019 Q2	$628K	Hold	200,000	–	–	0.24%	40
2019 Q1	$7.33M	Hold	200,000	–	–	3.14%	9
2018 Q4	$580K	Buy	+200,000	New	+$549K	0.29%	36

Other funds holding PDLI

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return

JBF Capital Aspen, Colorado $764M AUM 24.26% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Hancock Whitney Gulfport, Mississippi $6B AUM 34.57% 1-Year Est. Return

Alan W. Weber's PDLI Position: Q4 2020 in Review

Alan W. Weber sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 200,000 shares — an estimated $630K sold.

Alan W. Weber first reported a position in PDLI in Q4 2018 and held it in 8 quarters. The position peaked at $7.33M in Q1 2019. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

Alan W. Weber reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
Alan W. Weber sold 200,000 PDL BioPharma, Inc. shares in Q4 2020, an estimated $630K.
Alan W. Weber first reported a position in PDL BioPharma, Inc. in Q4 2018 and held it in 8 quarters.
Alan W. Weber's PDL BioPharma, Inc. position peaked at $7.33M in Q1 2019.
33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Alan W. Weber's 13F filing for Q4 2020, filed 16 Feb 2021.